The licence agreement will grant TerpeneTech the right to use Eden's terpene encapsulation system, for specific applications initially, within the consumer and agro-industrial biocide areas.
A licence fee of €100,000 will be payable to Eden, as well as on-going royalties on net sales of products.
The marketing agreement will provide TerpeneTech with access to Eden's Geraniol, Eugenol and Thymol dossiers for use with existing and new un-encapsulated consumer and agro-industrial biocide products, in return for royalties on net sales.
TerpeneTech is a newly formed 'partnership' which brings together a number of parties who are experienced in the biocide products market.
Eden MD Clive Newitt has been appointed as a director of TerpeneTech to provide both technical and marketing support.